These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 8558453)
21. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study. Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843 [TBL] [Abstract][Full Text] [Related]
22. Modulation of the gene expression of N-methyl-D-aspartate receptor NR2B subunit in the rat neostriatum by a single dose of specific antisense oligodeoxynucleotide. Sze SC; Wong CK; Yung KK Neurochem Int; 2001 Oct; 39(4):319-27. PubMed ID: 11551672 [TBL] [Abstract][Full Text] [Related]
23. Ablation of gene expression of N-methyl-D-aspartate receptor one by antisense oligonucleotides in striatal neurons in culture. Lui PW; Yeung CW; Yung WH; Shi Y; Chen LW; Chan YS; Yung KK Neurosignals; 2005; 14(6):303-16. PubMed ID: 16772733 [TBL] [Abstract][Full Text] [Related]
24. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Sheng M; Cummings J; Roldan LA; Jan YN; Jan LY Nature; 1994 Mar; 368(6467):144-7. PubMed ID: 8139656 [TBL] [Abstract][Full Text] [Related]
26. Distinct expression of phosphorylated N-methyl-D-aspartate receptor NR1 subunits by projection neurons and interneurons in the striatum of normal and amphetamine-treated rats. Liu Z; Mao L; Parelkar NK; Tang Q; Samdani S; Wang JQ J Comp Neurol; 2004 Jun; 474(3):393-406. PubMed ID: 15174082 [TBL] [Abstract][Full Text] [Related]
27. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Campbell BM; Kreipke CW; Walker PD Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829 [TBL] [Abstract][Full Text] [Related]
28. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. Landwehrmeyer GB; Standaert DG; Testa CM; Penney JB; Young AB J Neurosci; 1995 Jul; 15(7 Pt 2):5297-307. PubMed ID: 7623152 [TBL] [Abstract][Full Text] [Related]
29. Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Rudolf GD; Cronin CA; Landwehrmeyer GB; Standaert DG; Penney JB; Young AB Neuroscience; 1996 Jul; 73(2):417-27. PubMed ID: 8783259 [TBL] [Abstract][Full Text] [Related]
30. In situ hybridization of antisense mRNA oligonucleotides for AMPA, NMDA and metabotropic glutamate receptor subtypes in the rat suprachiasmatic nucleus at different phases of the circadian cycle. Gannon RL; Rea MA Brain Res Mol Brain Res; 1994 Jun; 23(4):338-44. PubMed ID: 8090074 [TBL] [Abstract][Full Text] [Related]
31. Diversity of glutamate receptor subunit mRNA expression within live hippocampal CA1 neurons. Mackler SA; Eberwine JH Mol Pharmacol; 1993 Aug; 44(2):308-15. PubMed ID: 7689143 [TBL] [Abstract][Full Text] [Related]
32. Glutamate receptor expression in rat striatum: effect of deafferentation. Wüllner U; Standaert DG; Testa CM; Landwehrmeyer GB; Catania MV; Penney JB; Young AB Brain Res; 1994 Jun; 647(2):209-19. PubMed ID: 7922497 [TBL] [Abstract][Full Text] [Related]
33. Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. Chen AC; McDonald B; Moss SJ; Gurling HM Brain Res Mol Brain Res; 1998 Feb; 54(1):92-100. PubMed ID: 9526055 [TBL] [Abstract][Full Text] [Related]
34. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. Meshul CK; Bunker GL; Mason JN; Allen C; Janowsky A J Neurochem; 1996 Nov; 67(5):1965-73. PubMed ID: 8863502 [TBL] [Abstract][Full Text] [Related]
35. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Standaert DG; Friberg IK; Landwehrmeyer GB; Young AB; Penney JB Brain Res Mol Brain Res; 1999 Jan; 64(1):11-23. PubMed ID: 9889300 [TBL] [Abstract][Full Text] [Related]
36. Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Frim DM; Wüllner U; Beal MF; Isacson O Exp Neurol; 1994 Aug; 128(2):172-80. PubMed ID: 8076661 [TBL] [Abstract][Full Text] [Related]
37. Mapping of the human NMDA receptor subunit (NMDAR1) and the proposed NMDA receptor glutamate-binding subunit (NMDARA1) to chromosomes 9q34.3 and chromosome 8, respectively. Collins C; Duff C; Duncan AM; Planells-Cases R; Sun W; Norremolle A; Michaelis E; Montal M; Worton R; Hayden MR Genomics; 1993 Jul; 17(1):237-9. PubMed ID: 8406459 [TBL] [Abstract][Full Text] [Related]
38. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Wang JQ; Daunais JB; McGinty JF Synapse; 1994 Dec; 18(4):343-53. PubMed ID: 7886627 [TBL] [Abstract][Full Text] [Related]